Henrik Rhenman

Rhenman & Partners is an active, long-term, niche manager which follows a long/short strategy focusing exclusively on innovative, fast-growing companies in the healthcare sector. They invest across subsectors, market-caps and geographies to lower volatility. The firm primarily invests in cash flow positive companies which have already received regulatory approval, aiming to mitigate event risk. They construct a diversified portfolio of select positions, roughly allocated equally between small- mid- and large-cap companies.

CF is an active investment manager following a growth-oriented investment approach. They invest in global equity across all market-caps, complemented with fixed-income, with the bulk of their investments in Swedish and US equity. Research is both performed in-house and shared with other Carnegie divisions. The firm's investment process is research-driven and starts with the analysis of long-term global trends. Sector allocation is top-down and based on macro-economic analysis focusing on the global economic cycle, inflation rates and development, future interest rate levels, and FX prices. Within select sectors, bottom-up stock-picking targets companies with growth potential. Stock selection is based on in-depth financial analysis, focusing on financial soundness, cash-flow analysis, profitability, growth history, management experience and ability, market position, ownership structure and stock liquidity. Company visits are part of the research process, as are reports by local analysts.